Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

34%

Beneficial ownership of this reported class.

Shares

255,429,406 shares

Shares beneficially owned as disclosed.

Event date

29 Jun 2026

Date tied to the ownership event or amendment.

Accepted by SEC

01 Jul 2026

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
OPK
Shares outstanding
749,059,842 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
01 Jul 2026, 16:04:37 UTC
Event date
29 Jun 2026
Prior SEC filing
01 Oct 2025
Source filing
View source filing

Key filing fact

Et al Phillip Frost MD disclosed 34% ownership in OPKO HEALTH, INC. Common Stock, par value $0.01 per share (OPK) on 29 Jun 2026.

Key facts

  • Et al Phillip Frost MD filed SCHEDULE 13D/A for OPKO HEALTH, INC. Common Stock, par value $0.01 per share (OPK).
  • Disclosed ownership: 34%.
  • Date of event: 29 Jun 2026.

Change

  • Previous schedule filing date: 01 Oct 2025.
  • Current filing was accepted on 01 Jul 2026, 16:04.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (3)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
FROST PHILLIP MD ET AL 34% 255,429,406 252,577,576 2,851,830 /s/ Phillip Frost, M.D. Phillip Frost, M.D., Individually 0000898860
Frost Gamma Investments Trust 29% 216,706,448 216,706,448 0 /s/ Phillip Frost, M.D. Phillip Frost, M.D. / Sole Trustee 0001380896
Frost Nevada Investments Trust 4% 30,127,177 30,127,177 0 /s/ Phillip Frost, M.D. Phillip Frost, M.D. / Sole Trustee 0001464124
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .